New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
10:00 EDTVECO, SNN, ITRI, EXXI, SCOR, ZTS, TRIP, ROLL, SGNT, SGEN, BUD, WCN, TCBK, PES, CROX, CNVR, SBMRYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Itron (ITRI) upgraded to Buy from Hold at Needham... Pioneer Energy (PES) upgraded to Buy from Speculative Buy at Global Hunter... RBC Bearings (ROLL) upgraded to Buy from Neutral at BofA/Merrill... Smith & Nephew (SNN) upgraded to Buy from Hold at Deutsche Bank... Sprint (S) upgraded to Buy from Hold at Deutsche Bank... TriCo Bancshares (TCBK) upgraded to Strong Buy from Outperform at Raymond James... TripAdvisor (TRIP) upgraded to Outperform from Sector Perform at RBC Capital... Veeco (VECO) upgraded to Outperform from Neutral at Credit Suisse... Waste Connections (WCN) upgraded to Buy from Hold at BB&T... Zoetis (ZTS) upgraded to Outperform from Market Perform at William Blair... SABMiller (SBMRY) upgraded to Conviction Buy from Buy at Goldman... AB InBev (BUD) upgraded to Buy from Sell at Goldman... comScore (SCOR) upgraded at Northland Securities... Conversant (CNVR) upgraded to Buy from Hold at Craig-Hallum... Seattle Genetics (SGEN) upgraded to Buy from Hold at Needham... Energy XXI (EXXI) upgraded to Buy from Accumulate at KLR Group... Crocs (CROX) upgraded to Overweight from Neutral at Piper Jaffray... Sagent Pharmaceuticals (SGNT) upgraded to Outperform at RBC Capital.
News For ITRI;PES;ROLL;SNN;TCBK;TRIP;VECO;WCN;ZTS;SBMRY;BUD;SCOR;CNVR;SGEN;EXXI;CROX;SGNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 19, 2015
14:46 EDTSCORcomScore announces global integration with Flurry from Yahoo
comScore (SCOR announced an integration with Flurry through Yahoo's (YHOO) Flurry Pulse solution, which will enable Flurry clients to streamline application tagging required for unified measurement in comScore Mobile Metrix and Media Metrix Multi-Platform. The beta period for this integration is expected to begin in the second quarter of 2015.
10:44 EDTTRIPOptions with decreasing implied volatility
Options with decreasing implied volatility: VDSI KING ZU AVP GRPN SKX TRIP YPF UPL CYBR
09:59 EDTPESOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:40 EDTPESPioneer Energy downgraded to Neutral from Accumulate at Global Hunter
Subscribe for More Information
08:16 EDTZTSZoetis price target raised tio $54 from $50 at Argus
Subscribe for More Information
07:42 EDTVECOVeeco price target lowered to $38 from $44 at UBS
Subscribe for More Information
07:31 EDTEXXIEnerCom to hold a conference
The Oil & Services Conference (TOSC) 2015 is being held in San Francisco on February 18-19 with webcasted company presentations to begin on February 19 at 11 am; not all company presentations may be webcasted. Webcast Link
07:05 EDTSGNTSagent Pharmaceuticals sees FY15 revenue $325M-$375M, consensus $343.29M
Subscribe for More Information
07:04 EDTSGNTSagent Pharmaceuticals reports Q4 EPS 94c, may not compare to consensus 1c
Subscribe for More Information
06:33 EDTSBMRYSABMiller CFO Jamie Wilson to resign for personal reasons
Subscribe for More Information
06:13 EDTCROXCrocs volatility elevated into Q4 and outlook
Subscribe for More Information
February 18, 2015
10:05 EDTVECOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agnico Eagle (AEM) upgraded to Overweight from Neutral at JPMorgan... Amarin (AMRN) upgraded to Buy from Neutral at SunTrust... Capital Product (CPLP) upgraded to Accumulate from Neutral at Global Hunter... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Danone (DANOY) upgraded to Neutral from Underperform at Exane BNP Paribas... Express (EXPR) upgraded on lower promotional activity at Piper Jaffray... Kforce (KFRC) upgraded to Outperform from Market Perform at Avondale... Legg Mason (LM) upgraded to Buy from Hold at Jefferies... Rackspace (RAX) upgraded following Q4 results at Pacific Crest... Rosetta Resources (ROSE) upgraded to Buy from Neutral at Global Hunter... SeaChange (SEAC) upgraded to Buy from Hold at Noble Financial... Valero (VLO) upgraded to Outperform from Neutral at Credit Suisse... Veeco (VECO) upgraded to Buy from Hold at Noble Financial... Wolverine World Wide (WWW) upgraded to Neutral from Underperform at Sterne Agee.
09:05 EDTSGENSeattle Genetics submits supplemental BLA to FDA for Phase 3 Aethera trial
Seattle Genetics announced that it has submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration based on data from the phase 3 AETHERA trial of ADCETRIS as consolidation therapy immediately following an autologous stem cell transplant in Hodgkin lymphoma patients at high risk of relapse. ADCETRIS is an antibody-drug conjugate directed to CD30, which is expressed in classical HL and systemic anaplastic large cell lymphoma. ADCETRIS is approved in relapsed HL and sALCL but is currently not approved for consolidation therapy in HL patients immediately after ASCT. The supplemental BLA is based on positive results from a phase 3 clinical trial called AETHERA that were presented at the 56th American Society of Hematology Annual Meeting in December 2014. Results from the AETHERA trial in 329 HL patients at high risk of relapse included: The trial achieved its primary endpoint and demonstrated a significant increase in progression-free survival per independent review facility, with a hazard ratio of 0.57 and a p-value of 0.001. Median PFS was 43 months for patients who received ADCETRIS versus 24 months for patients who received placebo. The two-year PFS rate was 63 percent in the ADCETRIS arm compared to 51 percent in the placebo arm. The PFS benefit was consistent across all pre-specified subgroups, including primary refractory patients, patients who relapsed within twelve months of frontline therapy and patients who relapsed after twelve months with extranodal disease.
08:05 EDTVECOVeeco upgraded to Buy from Hold at Noble Financial
Subscribe for More Information
February 17, 2015
17:18 EDTZTSPershing Square gives quarterly update on stakes
NEW STAKES: Restaurant Brands International (QSR). INCREASED STAKES: Zoetis (ZTS), and Platform Specialty Products (PAH). DECREASED STAKES: Allergan (AGN). LIQUIDATED STAKES: None.
16:19 EDTVECOVeeco sees Q1 EPS (13c)-(7c), consensus 14c
Subscribe for More Information
16:17 EDTVECOVeeco reports Q4 EPS 13c, consensus 4c
Subscribe for More Information
06:06 EDTPESPioneer Energy sees Q1 drilling rigs utilization 78%-80%
In Q1, drilling rigs utilization is expected to average 78%-80% based on an average fleet of 46 rigs. Drilling Services Segment margin is expected to be approximately $10,000-$11,000 per day, which includes a benefit from rigs earning but not working. Production Services Segment revenue in Q1 is expected to be down approximately 15%-20% as compared to Q4 due to overall reduction in industry activity. Production Services Segment margin as a percentage of revenues is expected to be down approximately 5%-7% as compared to Q4.
06:05 EDTPESPioneer Energy reports Q4 driling utilization of 89%
Subscribe for More Information
06:02 EDTPESPioneer Energy reports Q4 adjusted EPS 4c, consensus 11c
Reports Q4 revenue $283.1M, consensus $268.32M.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use